Pasithea Therapeutics (KTTA) Stock Chart & Stock Price History $0.69 0.00 (-0.22%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$0.68 -0.01 (-0.91%) As of 07/11/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Pasithea Therapeutics Stock Price Performance The Pasithea Therapeutics (KTTA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 87.69%, with a year-to-date return of -78.12%. In the past month, the stock has decreased 12.30%, reflecting recent market activity. As of the latest close, Pasithea Therapeutics traded at $0.69 with a market cap of $5.13 million and volume of 51,056 shares. Receive KTTA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pasithea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-4.40%1 Month Performance-12.30%3 Month Performance-51.46%Year-To-Date Performance-78.12%1 Year Performance-87.69% KTTA Stock Chart for Sunday, July, 13, 2025 KTTA Chart by TradingView Pasithea Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/11/2025$0.69$0.69-0.22%$0.69$0.6851,056 shs$5.13 million07/10/2025$0.70$0.69-1.16%$0.70$0.6971,343 shs$5.14 million07/09/2025$0.72$0.70-3.07%$0.72$0.67158,416 shs$5.20 million07/08/2025$0.72$0.72+0.61%$0.74$0.7089,063 shs$5.37 million07/07/2025$0.74$0.72-2.77%$0.75$0.7241,512 shs$5.33 million07/04/2025$0.74$0.74$0.77$0.7367,101 shs$5.49 million07/03/2025$0.75$0.74-1.44%$0.77$0.7367,101 shs$5.48 million07/02/2025$0.73$0.75+1.80%$0.75$0.7077,655 shs$5.56 million07/01/2025$0.72$0.73+1.84%$0.74$0.7193,498 shs$5.47 million06/30/2025$0.76$0.72-4.97%$0.75$0.70179,948 shs$5.37 million Get the Latest News and Ratings for KTTA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pasithea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/27/2025$0.73$0.76+3.41%$0.76$0.72123,334 shs$5.65 million06/26/2025$0.72$0.73+1.45%$0.75$0.7188,697 shs$5.46 million06/25/2025$0.73$0.72-1.03%$0.75$0.7164,658 shs$5.39 million06/24/2025$0.72$0.73+1.63%$0.74$0.71139,351 shs$5.44 million06/23/2025$0.75$0.72-3.84%$0.73$0.71118,114 shs$5.35 million06/20/2025$0.77$0.75-3.43%$0.80$0.75299,809 shs$5.57 million06/19/2025$0.77$0.77$0.78$0.76176,658 shs$5.76 million06/18/2025$0.80$0.77-3.05%$0.78$0.76176,658 shs$5.76 million06/17/2025$0.77$0.80+3.12%$0.83$0.79171,908 shs$5.95 million06/16/2025$0.79$0.77-1.42%$0.80$0.71345,243 shs$5.77 million06/13/2025$0.83$0.79-5.21%$0.84$0.77290,893 shs$5.85 million06/12/2025$0.85$0.83-2.33%$0.87$0.82157,143 shs$6.17 million Related Companies Dare Bioscience Stock Price Chart Aytu BioPharma Stock Price Chart Finch Therapeutics Group Stock Price Chart Natural Alternatives International Stock Price Chart Sol-Gel Technologies Stock Price Chart Relmada Therapeutics Stock Price Chart DURECT Stock Price Chart VYNE Therapeutics Stock Price Chart Briacell Therap Stock Price Chart JATT Acquisition Stock Price Chart Receive KTTA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pasithea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KTTA) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pasithea Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pasithea Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
